Asklepion Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Asklepion Pharmaceuticals

Access the complete profile.

Asklepion Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	729 East Pratt Street Suite 360 Baltimore, MD 21202

Note: Revenues for privately held companies are statistical evaluations.


Asklepion Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Asklepion Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Asklepion Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Asklepion Pharmaceuticals Annual Revenue and Growth Rate

Asklepion Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Asklepion Pharmaceuticals's revenues are gauged from an analysis of company filings.

Asklepion Pharmaceuticals's Income Statement (based on Industry Averages)

Asklepion Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Asklepion Pharmaceuticals is developing and marketing. Asklepion Pharmaceuticals doesn't have any recent trademark applications, indicating Asklepion Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TURNOBI Pharmaceutical products in the nature of preventatives for acute lung injury induced by cardiopulmonary bypass in pediatric patients	06/15/2017
ASKLEPION GROWTH HEALTH INNOVATION Pharmaceutical research and development	06/12/2016
CHOLABAM Pharmaceutical preparations for use in treatment of individuals with primary and secondary defects in bile acid synthesis	03/22/2013

See all trademarks and details in the Full Report.

Market Share of Asklepion Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Asklepion Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Asklepion Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
USALCO	Curtis Bay, MD	100
DPA INVESTMENTS	Baltimore, MD	55
J. C. PARRY & SONS	Baltimore, MD	4
SUMMIT CHEMICAL	Baltimore, MD	3
CLEANEDGE	Baltimore, MD	2
CHEMPACIFIC	Baltimore, MD	2
PRINCE SPECIALTY PRODUCTS	Baltimore, MD	2
ALPHA BIOSCIENCES	Baltimore, MD	1
ASKLEPION PHARMACEUTICALS	Baltimore, MD	1
KAUFMAN REAL ESTATE ENTERPRISES	Baltimore, MD	1

Other Companies at 729 East Pratt Street, Baltimore MD

Company	Headquarters	Revenue ($ MM)
MIDATLANTICBROADBAND	Baltimore, MD	100
PROTEL SERVICES	Baltimore, MD	41
CMD INVESTMENT GROUP	Baltimore, MD	24
CAREER COMMUNICATIONS GROUP	Baltimore, MD	9
AUSIO PHARMACEUTICALS	Baltimore, MD	2

Future Competition: Asklepion Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Asklepion Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)